Latest News Archive

Please select Category, Year, and then Month to display items
Years
2019 2020 2021 2024
Previous Archive
11 October 2019 | Story Leonie Bolleurs | Photo Supplied
Staff and Students from the Department of Physics
Staff and students from the UFS Department of Physics with parts of the newly arrived astronomical spectrograph for the Boyden Observatory 1,5-m telescope. From the left, are: Dr Pat van Heerden, Daniel Kulik (honours student), Joleen Els (third-year student), Justin Cooper (honours student), Helene Szegedi (lecturer), Professor Petrus Meintjes, Dr Brian van Soelen, and Dr Richard Gray.

Stable atmospheric environments and near perfect weather conditions were the main reasons for the establishment of the Boyden Observatory a few kilometres outside Bloemfontein. This astronomical research observatory and science education centre is managed by the Department of Physics at the University of the Free State (UFS).

With the newly acquired astronomical spectrograph for the Boyden Observatory 1,5-m telescope, scientists will be able to gain visual access to both the Northern and Southern Hemisphere skies.

Collaboration with expert in stellar spectroscopy 


The spectrograph, mainly developed and built by Dr Richard Gray, will be used collaboratively for astronomical research by the UFS and the Appalachian State University (ASU) in North Carolina, where Dr Gray is based. 

Dr Gray is a world-renowned expert in stellar spectroscopy and leading author of one of the most influential textbooks on stellar spectroscopy, Stellar Spectral Classification, with co-author Christopher J Corbally.

Dr Gray recently received a Fulbright Scholarship from the Fulbright Foundation to spend a full year in the UFS Department of Physics, where he will lecture several Astronomy classes and do research in collaboration with personnel of the UFS Astrophysics Research Group. He will also lead the assembly of the instrument over the next few weeks, working with personnel and students in the Department of Physics as well as the UFS Instrumentation Division.

According to Prof Pieter Meintjes, Senior Professor from the UFS Department of Physics, some components of the instrument have been developed and constructed by the university’s Instrumentation Division, with key components purchased from funding by the Directorate: Research Development at the UFS.

Unique capability in infrastructure 

“The availability of a sophisticated instrument of this nature on the 1,5-m telescope will place the UFS Astrophysics Group in an elite bracket in terms of the available infrastructure for astronomical research,” said Prof Meintjes.

He explained: “The combined polarimetric-spectroscopic capability in one single instrument is unique. Combined with the fact that it is hosted on a research instrument that is utilised and maintained exclusively by the UFS Astronomy Group in the Department of Physics, gives this group a competitive edge in relation to most international astronomy groups.” 

The instrument is valued at close to R1,5 million. 

The Boyden Observatory
The Boyden Observatory. (Photo:Supplied)

According to Prof Meintjes, the instrument will be mounted at the backend of the UFS Boyden 1,5-m telescope and will allow them to do simultaneous polarimetry and spectroscopy of astronomical sources. “This is vital for the research we are working on,” he said.

International collaboration and student development

The instrument also brings with it the possibility of forging international collaborations for research as well as student development. “This can advance the stature of the UFS as an internationally respected research-led tertiary institution,” said Prof Meintjes. 

The possibility of making the UFS Boyden 1,5-m telescope completely remote-controlled, is being investigated. “This will serve the observational needs of researchers from both the UFS and the ASU, with researchers at ASU able to access the telescope for their own in-house research programmes. The availability of such an instrument on the UFS 1,5-m telescope also opens up the possibility to accommodate visiting researchers from ASU or elsewhere in the world at Boyden,” said Prof Meintjes.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept